PPIs increase hip fracture risk

Postmenopausal women who regularly use proton pump inhibitors are at increased risk of suffering hip fractures.

Long wait over for hep C therapy

The first new hepatitis C therapy in more than a decade has been approved by the national watchdog for drugs...

Metformin may reduce pancreatic cancer risk in women only

The diabetes drug Metformin, previously linked with reduced pancreatic cancer risk, has been found by a new large-scale study to...

Experts call for FIT standardisation

Differences in naming, measurement and reporting of results between different fecal immunochemical tests are holding the method back, argue Australian...

Infliximab gets the (foot) drop on patient

Clinicians should be aware of peripheral neuropathy as a rare complication of anti- TNF therapy, experts warn.

Warning on GI symptoms with paracetamol: study

Researchers were surprised when a control arm receiving only paracetamol experienced the same drops in haemoglobin as the ibuprofen group.

Some bisphosphonates may halve CRC risk: study

Patients taking bisophosphonates may reduce their cancer risk by taking particualar drugs in the class, suggests preliminary research.

New C.difficile strain hits Australia

A new, hypervirulent strain of Clostridium difficile may be taking hold in Australia, specialists warn, after a man acquired the...

Bariatric surgery eases migraine

Weight-loss surgery can alleviate migraine in severely obese individuals, a small observational study finds.

Anti-TNF for Crohn’s on PBS

The anti-TNF adalimumab (Humira) will be available on the Pharmaceutical Benefits Scheme from this Friday for the treatment of adults...

Medical journals still haunted by ghostwriters

Ghostwriting in medical journals is equivalent to fraud and should be punished as such, argue lawyers.

New evidence backs expansion of bowel cancer screening

Cancer experts say new evidence backs the already persuasive case to extend bowel cancer screening program from one off tests...

Season's greetings!

As this is the last issue of Gastroenterology Update for 2011 our editorial team would like to wish you a...

Barbies blamed for reflux

Being overweight and consuming barbecued meat are two of the main factors explaining why one in ten Australians experience regular...

New tool predicts GIST outcomes

Most gastrointestinal stromal tumour patients are cured by surgery alone and do not benefit from adjuvant imatinib therapy.